Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
MH Le, DM Le, TC Baez, Y Wu, T Ito, EY Lee… - Journal of …, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
Non-alcoholic fatty liver disease–a global public health perspective
ZM Younossi - Journal of hepatology, 2019 - Elsevier
As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
Chronic hepatitis B virus infection
Chronic hepatitis B virus infection is a global public health threat that causes considerable
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …
New trends on obesity and NAFLD in Asia
Traditionally, obesity and its related diseases have been considered a problem in Western
countries. However, in the past two decades, urbanisation in many Asian countries has led …
countries. However, in the past two decades, urbanisation in many Asian countries has led …
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment
Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …
The Asia–Pacific Working Party on non‐alcoholic fatty liver disease guidelines 2017—part 2: management and special groups
How to assess efficacy of interventions. In clinical practice, and particularly among those
who appear to have mild liver disease, it may be sufficient to note changes (normalization) of …
who appear to have mild liver disease, it may be sufficient to note changes (normalization) of …
[HTML][HTML] Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
SC Huang, CJ Liu - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has
increased among the general population and chronic hepatitis B (CHB) patients worldwide …
increased among the general population and chronic hepatitis B (CHB) patients worldwide …
Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B
Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …
Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B
Background As the prevalence of hepatitis steatosis (HS) increases, the prevalence of HS
among those with chronic hepatitis B (CHB) may also be increasing but data on the effect of …
among those with chronic hepatitis B (CHB) may also be increasing but data on the effect of …